Evidence map›Paper›PMID 40785829›Full record

ArticleCirculation reports2025

Morphological Re-Evaluation of Cardiac Sarcoidosis - A Case-Based Analysis of 14 Post-Mortem Japanese Hearts.

Hiromoto Sone, Hitomi Kera, Kinta Hatakeyama, Junko Nakashima, Takafumi Ogawa, Toshiko Onizuka-Yamochi, Hiroshi Suzuki, Hatsue Ishibashi-Ueda, Taka-Aki Matsuyama

Abstract read
In one paragraph

Article in Circulation reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Hiromoto Sone *Department of Legal Medicine, School of Medicine, Showa Medical University Tokyo Japan.
Hitomi Kera *Department of Pathology, School of Medicine, Showa Medical University Tokyo Japan.
Kinta HatakeyamaDepartment of Pathology, National Cerebral and Cardiovascular Center Osaka Japan.
Junko NakashimaDepartment of Diagnostic Pathology, Chikamori Hospital Kochi Japan.
Takafumi OgawaDepartment of Pathology and Division of Cardiology, Department of Internal Medicine, Fujigaoka Hospital, Showa Medical University Yokohama Japan.
Toshiko Onizuka-YamochiDepartment of Pathology, School of Medicine, Showa Medical University Tokyo Japan.
Hiroshi SuzukiDepartment of Pathology and Division of Cardiology, Department of Internal Medicine, Fujigaoka Hospital, Showa Medical University Yokohama Japan.
Hatsue Ishibashi-UedaDepartment of Pathology, National Cerebral and Cardiovascular Center Osaka Japan.
Taka-Aki MatsuyamaDepartment of Legal Medicine, School of Medicine, Showa Medical University Tokyo Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Cardiac sarcoidosis is a major cause of secondary cardiomyopathy leading to lethal arrhythmias and heart failure; however, identifying specific imaging findings of cardiac sarcoidosis remains a major issue. We re-examined the macroscopic morphology of post-mortem hearts to identify and reconfirm crucial findings for the clinical diagnosis of cardiac sarcoidosis. Methods and Results: We examined 14 autopsied hearts from patients who were diagnosed with cardiac sarcoidosis from 2002 to 2019 at several medical institutions in Japan. The cases were classified into 2 groups: ante-mortem diagnosis (Group A, n=8), and post-mortem diagnosis (Group B, n=6). Of the 14 hearts, steroids were only administered in Group A. Seven macroscopic features were re-evaluated in all hearts: (1) epicardial irregularity (n=5); (2) fibrosis in the posterior interventricular junction (n=11); (3) ventricular septum wall thinning (n=9); (4) diffuse left ventricular wall thinning (n=4); (5) ventricular aneurysms (n=3); (6) papillary muscle deformities (n=12); and (7) white colored fibrosis (n=8). Conclusions: This study highlights the underreported macroscopic findings of cardiac sarcoidosis. The 7 features highlight the uniqueness of cardiac sarcoidosis, which warrants recognition of this disease as a distinct pathological entity rather than merely a dilated cardiomyopathy-like secondary cardiomyopathy.

Indexed as

Cardiac sarcoidosisFibrosisPathologySecondary cardiomyopathySteroid

Identifiers

PMID40785829
PMCPMC12331346

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.